| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.01 | 1 |